 SEATTLE, WA and VANCOUVER, BC ACCESSWIRE August 3, 2021 Achieve Life Sciences, Inc. NASDAQ:ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its second quarter 2021 financial results and provide an update on the cytisinicline development program on Thursday, August 12, 2021 at 4:30PM EDT. To access the webcast, log on to the Investor Relations page of the Achieve website at 